To Order: patrick@cotinis.com
Phospho-Lck (Tyr394) Antibody |
|||
| AF7194 | Affbiotech | 200ul | EUR 540 |
Phospho-LCK (Tyr394) Antibody |
|||
| CSB-PA096222- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against Phospho-LCK (Tyr394). Recognizes Phospho-LCK (Tyr394) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
Phospho-LCK (Tyr394) Antibody |
|||
| CSB-PA096222-100ul | Cusabio | 100ul | EUR 434.4 |
|
Description: A polyclonal antibody against Phospho-LCK (Tyr394). Recognizes Phospho-LCK (Tyr394) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
|||
Phospho-GDF9 (Tyr394) Antibody |
|||
| AF7035 | Affbiotech | 200ul | EUR 540 |
Mdm2 p53 Binding Protein Homolog Phospho-Tyr394 (MDM2 pY394) Antibody |
|||
| 20-abx326263 | Abbexa |
|
|
Phospho-Lck (Tyr393)[Tyr394] Antibody |
|||
| AF3101 | Affbiotech | 200ul | EUR 420 |
Phospho-LCK (Tyr394) Monoclonal Antibody |
|||
| A1027-100 | Biovision | each | EUR 444 |
Anti-Phospho-MDM2 (Tyr394) antibody |
|||
| STJ98946 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to Phospho-MDM2 (Tyr394). |
|||
MDM2(Phospho-Ser260) antibody |
|||
| 12171-100ul | SAB | 100ul | EUR 399.6 |
MDM2 (phospho-Ser166) Antibody |
|||
| 11550-100ul | SAB | 100ul | EUR 302.4 |
MDM2 (phospho-Ser166) Antibody |
|||
| 11550-50ul | SAB | 50ul | EUR 224.4 |
Phospho- MDM2 (Ser166) Antibody |
|||
| ABF3376 | Lifescience Market | 100 ug | EUR 525.6 |
MDM2 Antibody (phospho-T218) |
|||
| F48546-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: MDM2 is a target of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of MDM2 can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle,apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5. |
|||
MDM2 Antibody (phospho-S395) |
|||
| F48579-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: MDM2 is a target of the transcription factor tumor protein p53. This protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of MDM2 can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. MDM2 also affects the cell cycle,apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5. |
|||
Phospho-Lck (Tyr394) Blocking Peptide |
|||
| AF7194-BP | Affbiotech | 1mg | EUR 234 |
Phospho-GDF9(Tyr394) Blocking Peptide |
|||
| AF7035-BP | Affbiotech | 1mg | EUR 234 |
MDM2 (Phospho-Ser186/Ser188) Antibody |
|||
| 11702-100ul | SAB | 100ul | EUR 302.4 |
MDM2 (Phospho-Ser186/Ser188) Antibody |
|||
| 11702-50ul | SAB | 50ul | EUR 224.4 |